Thomas J. Riga - 15 Mar 2022 Form 4 Insider Report for SPECTRUM PHARMACEUTICALS INC

Role
CEO & President, Director
Signature
/s/ Kurt A. Gustafson, attorney-in-fact for Thomas J. Riga
Issuer symbol
N/A
Transactions as of
15 Mar 2022
Net transactions value
-$27,644
Form type
4
Filing time
16 Mar 2022, 18:29:19 UTC
Previous filing
24 Feb 2022
Next filing
23 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPPI Common Stock, $0.001 par value Sale $14,351 -20,356 -3.3% $0.7050 587,629 15 Mar 2022 Direct F1
transaction SPPI Common Stock, $0.001 par value Sale $13,293 -18,829 -3.2% $0.7060 568,800 16 Mar 2022 Direct F1
holding SPPI Common Stock, $0.001 par value 14,139 15 Mar 2022 By 401(k) plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.